Clinical Trial

Group Treatment for Self-harming Adolescents and Their Parents: a Randomized Controlled Trial

Study acronym: ERA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Adolescent non-suicidal self-injury (NSSI) is common, strongly associated with psychiatric comorbidity and an increased risk of future suicide attempt. Although interventions targeting emotion regulation have been shown to reduce NSSI in both adults and adolescents few, are available within routine child and adolescent mental health services (CAMHS). Emotion Regulation for Adolescents (ERA), adapted from an evidence-based adult intervention is a brief group-based treatment designed to increase access to effective, evidence-based care for adolescents with NSSI. A large-scale randomised controlled trial (RCT) is needed to establish its efficacy and strengthen the evidence base for emotion regulation interventions for adolescent NSSI. The overall aim of this project is to increase the availability of evidence-based psychological treatments for adolescent NSSI by developing and evaluating Emotion Regulation for Adolescents (ERA), a novel behavioural and acceptance-based intervention. The main objectives are to establish the efficacy, cost-effectiveness, and long-term outcomes of ERA for adolesent NSSI in two arm RCT comparing ERA with an active control condition (FUNK) as well as to investigate potential mediators such as emotion regulation and self-criticism.
Trial Details
NCT Number NCT07720063
Lead Sponsor Karolinska Institutet
Collaborators: Västra Götalandsregionen, Region Stockholm
Conditions Self-Harm, Self-Harm, Deliberate, Self-harm Behavior, Non-Suicidal Self Injury, Non-suicidal Self-injury (NSSI)
Enrollment 180 participants
Start Date 2026-08-17
Primary Completion 2032-12-31 (estimated)
Study Completion 2034-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-22